RxDoctor Payments Data

Rebecca Koehl, MD

Family Medicine · Fairfield, OHNPI 1841289477

Payments from drug & device makers

$695in general payments, 2019–2025

Across 40 payments — averaging $17.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$98
  • Exact Sciences$80
  • Abbott$76
  • Amgen$69
  • Imperative Care, Inc$51
  • AbbVie$50
  • plus $272 from 16 others

What the payments were for

  • Food & beverage$695100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$695 in reported general payments places this provider in the 55th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$115,952
Medicare patients
296
Services billed
1,399

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin172$157,114
MounjaroTirzepatide99$119,510
OzempicSemaglutide76$95,221
EliquisApixaban80$89,917
JanuviaSitagliptin Phosphate43$44,384
XareltoRivaroxaban48$43,838
TrulicityDulaglutide26$32,788
KerendiaFinerenone24$26,068
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog66$24,299
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog28$21,079
EntrestoSacubitril/Valsartan11$16,243
FarxigaDapagliflozin Propanediol16$13,661
Lantus SolostarInsulin Glargine,hum.Rec.Anlog95$12,649
Breo ElliptaFluticasone/Vilanterol27$11,885
Spiriva RespimatTiotropium Bromide11$8,080

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$11$165,194183 claims
Lilly USA, LLCMounjaro, Trulicity$13$152,298125 claims
Novo NordiskOzempic$31$95,22176 claims
PfizerEliquis, Paxlovid$98$92,710102 claims
MerckJanuvia, Belsomra$18$49,89256 claims
Johnson & JohnsonXarelto$12$43,83848 claims
BayerKerendia$16$26,06824 claims
NovartisEntresto$16$16,24311 claims
AstraZenecaFarxiga$14$13,66116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Fairfield

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →